Price $107.64 |
Market Cap
1.76B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
39.7
|
P/B
2.82
|
P/S
1.87
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
17.3
|
Op. Cash Flow
106K
|
FCF
6.3
|
|
Op. Margin
7.20%
|
Net Margin
4.80%
|
ROE
7.50%
|
ROI
6.40%
|
|
ROA
4.60%
|
EPS Growth
8.60%
|
Current Ratio
2.8
|
Debt/Equity
38.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| LogicMark Inc (LGMK) | $0.69 | - | - | 7.3M | Strong Buy |
| Vericel Corp (VCEL) | $21.47 | - | - | 1.18B | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $2.37 | - | - | 12.9M | Strong Buy |
| Societal CDMO Inc (SCTL) | $1.81 | - | - | 85M | Strong Buy |
| Biomerica Inc (BMRA) | $4.17 | - | - | 41.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
